HomeAVTX • NASDAQ
add
Avalo Therapeutics Inc
Previous close
$7.00
Day range
$6.60 - $7.47
Year range
$3.95 - $34.46
Market cap
71.41M USD
Avg Volume
123.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 249.00K | 5.51% |
Operating expense | 6.61M | 76.56% |
Net income | 23.04M | 540.65% |
Net profit margin | 9.25K | 517.64% |
Earnings per share | — | — |
EBITDA | -12.83M | -245.83% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 81.86M | 704.11% |
Total assets | 98.46M | 236.37% |
Total liabilities | 75.72M | 419.53% |
Total equity | 22.73M | — |
Shares outstanding | 10.39M | — |
Price to book | 3.21 | — |
Return on assets | -31.10% | — |
Return on capital | -268.53% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 23.04M | 540.65% |
Cash from operations | -11.53M | -68.62% |
Cash from investing | 0.00 | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -11.53M | -398.70% |
Free cash flow | -42.30M | -782.55% |
About
Founded
2011
Headquarters
Website
Employees
19
